JRJosefina Guadalupe Rodríguez-González

Josefina Guadalupe Rodríguez-González

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Josefina Guadalupe Rodríguez-González has a total of 40 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Artificial Intelligence and Digital Health in the Diagnosis of Leprosy: Current Advances and Future Perspectives

    by Gerardo Rivera, Raúl Rubio, Luis Rodríguez, Josefina Rodríguez, Augusto Salinas, David Orozco, Francisco González, María Moreno

    Leprosy remains a significant public health challenge in endemic regions, where delayed diagnosis leads to irreversible nerve damage, disability, and ongoing transmission. To address the need for innovative diagnostic strategies, artificial intelligence (AI) and digital health technologies have emerged as promising tools. This review explores the current applications of machine learning, deep learning, computer vision, and mobile health platforms in leprosy diagnosis and management. AI-based image analysis demonstrates strong potential for identifying characteristic skin lesions and differentiating leprosy from other dermatological conditions. Additionally, predictive algorithms and smartphone-based telemedicine expand access to specialized care in underserved settings while facilitating contact tracing, surveillance, and treatment monitoring. Despite these encouraging advances, significant challenges remain, including limited high-quality annotated datasets, algorithmic bias, a lack of external validation, and data privacy concerns. Ultimately, AI-driven digital health solutions should complement rather than replace clinical expertise. Prioritizing multicenter collaborations, explainable AI models, and secure data integration will be essential to strengthen global leprosy control programs, improve patient outcomes, and reduce the burden of this neglected tropical disease.

  • Metabolic Pathways and Metabolite Yields for the Technology Energy Production for Human Consume

    by Rodríguez- Martínez, Luis Mario, Rodríguez- González, Josefina Guadalupe, Ríos- Saldaña, Carlos Antonio, Medina- Ramírez, M. C. Carlo Franco, Rodríguez- Pérez, Mario Alberto

  • Open Access

    Host Immune Responses to SARS-CoV-2 Vaccination in Northern Mexico: Structural Biology Insights and the Impact of Obesity

    by Carlo F. Medina-Ramírez, Jose L. Chavelas-Reyes, Josefina G. Rodríguez-González, Nadia A. Fernández-Santos, Lihua Wei, Francisco J. Cabrera-Santos, Eli J. Fuentes-Chávez, Luis M. Rodríguez-Martínez, Mario A. Rodríguez Pérez

    Understanding the molecular mechanisms underlying host immune responses to SARS-CoV-2 vaccination remains essential, particularly in populations with a high prevalence of obesity. In this cross-sectional study, we evaluated whether body mass index (BMI) is associated with vaccine-induced humoral immunity in a cohort from northeastern Mexico and discuss the findings within a structural immunology framework of spike antigenicity and antibody–epitope interactions. A total of 138 adults were recruited in Reynosa and Matamoros (June 2021–June 2022) and categorized as healthy weight, overweight, or obese according to BMI criteria. Serum anti-SARS-CoV-2 IgG was assessed using an ELISA-based assay, and differences across BMI groups were tested using the Kruskal–Wallis approach. Among all participants, 33.3% were classified as obese and 99.3% (137/138) were seropositive for anti-SARS-CoV-2 IgG. No significant differences in IgG levels were detected between BMI categories (p = 0.20). These results indicate that, in this Mexican cohort—sampled during a period of heterogeneous and often incomplete vaccination schedules—obesity was not associated with reduced detectable anti-SARS-CoV-2 IgG responses. Our findings support the need to integrate population-level serology with mechanistic studies that interrogate antibody quality (e.g., neutralization potency and epitope specificity) to better connect clinical determinants such as obesity with molecular correlates of protection.

  • Open Access

    Bovine Tuberculosis as a Neglected Zoonotic Disease in Mexico and Latin America: Epidemiological Challenges, Diagnostic Insights, and Public Health Implications in Emerging Economies

    by Luis M. Rodríguez-Martínez, Jose L. Chavelas-Reyes, Carlo F. Medina-Ramírez, Jorge A. Valdés-González, Eli Fuentes-Chávez, Carlos A. Ríos-Saldaña, Miguel A. de León-Zapata, Josefina G. Rodríguez-González

    Bovine tuberculosis (bTB), caused by Mycobacterium bovis, remains one of the most relevant zoonotic diseases worldwide due to its dual impact on livestock production and human health. Although zoonotic tuberculosis has been virtually eradicated from cattle in a few settings, particularly in Australia, the disease persists in much of Latin America, Africa, and Asia, where it continues to limit cattle productivity and pose a threat to public health through the consumption of unpasteurized dairy products and occupational exposure. This review integrates historical, epidemiological, clinical, and molecular perspectives of bTB, with particular emphasis on Mexico, highlighting the role of wildlife reservoirs, socioeconomic factors, and diagnostic limitations in maintaining endemicity. Recent advances in molecular epidemiology, such as PCR, MIRU-VNTR, and whole-genome sequencing, provide promising avenues for surveillance and control. Finally, we discuss the importance of adopting a One Health framework that bridges veterinary, medical, and environmental approaches to achieve sustainable control of this silent zoonosis.


  • Open Access

    Molecular Epidemiology of Mycobacterium tuberculosis in Mexico

    by Luis M. Rodríguez-Martínez, Jose L. Chavelas-Reyes, Carlo F. Medina-Ramírez, Eli Fuentes-Chávez, Zurisaday S. Muñoz-Troncoso, Ángeles G. Estrada-Vega, Enrique Rodríguez-Díaz, Diego Torres-Morales, María G. Moreno-Treviño, Josefina G. Rodríguez-González

    Tuberculosis (TB), caused by Mycobacterium tuberculosis, continues to be a leading cause of morbidity and mortality in Mexico, with more than 20,000 new cases annually and a rising proportion of drug-resistant strains. This work addresses the molecular epidemiology of TB in the Mexican context, emphasizing its role in understanding transmission, genetic diversity, and resistance mechanisms. To achieve this, we reviewed molecular typing approaches including spoligotyping, Mycobacterial Interspersed Repetitive Unit–Variable Number Tandem Repeat (MIRU-VNTR) analysis, and whole-genome sequencing (WGS), which have been applied to characterize circulating lineages and identify drug-resistance-associated mutations. The results indicate that the Euro-American lineage (L4) predominates across the country, although significant regional variation exists, with Haarlem, LAM, T, and X sub lineages dominating in different states, and occasional detection of Asian (L2) and Indo-Oceanic (L1) lineages. Key resistance mutations were identified in katG, rpoB, pncA, and gyrA, contributing to the emergence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) strains, particularly in border and marginalized regions. These findings highlight how social factors, such as migration, urban overcrowding, and comorbidities including diabetes and HIV, influence transmission dynamics. We conclude that integrating molecular tools with epidemiological surveillance is crucial for strengthening public health strategies and guiding interventions tailored to Mexico’s heterogeneous TB burden.


  • Open Access

    Gender, Immunological Response, and COVID-19: An Assessment of Vaccine Strategies in a Pandemic Region of Oaxaca, México

    by Luis M. Rodríguez-Martínez, José L. Chavelas-Reyes, Carlo F. Medina-Ramírez, Francisco J. Cabrera-Santos, Nadia A. Fernández-Santos, Jesús A. Aguilar-Durán, Sonia M. Pérez-Tapia, Josefina G. Rodríguez-González, Mario A. Rodríguez Pérez

    COVID-19 is no longer a public health emergency of international concern, but long COVID’s effects are yet to be fully understood. Hence, globally, SARS-CoV-2 is still a profound threat to public health and of perilous nature as a zoonotic disease. Timely vaccination provided to individuals worldwide during the pandemic phase was under a certain degree of control; however, few studies have reported the effectiveness of vaccines administered in Mexico, and its surveillance is paramount. Furthermore, an unknown proportion of Mexican individuals have not yet received any vaccine, and the circulation of the Omicron, Pirola, and FLiRT variants is ongoing. A cross-sectional serology survey study design was employed, involving 150 individuals from Southern Mexico (Oaxaca) whose humoral immune responses after vaccination were tested by an ELISA; the receptor-binding domain of the SARS-CoV-2 spike protein served as a recombinant antigen in the ELISA. One hundred thirty-nine out of 150 individuals (92.6%; 95%-CI = 87–95%) examined were positive for the ELISA, but in 11 individuals, the vaccines did not induce any immune response. Interestingly, the immune responses (antibody prevalence and levels) of females (58%) were higher (T= −2.21; p-value = 0.02) than those of males (41%). However, in this sample population of Southern Mexico, age, vaccine type, comorbidity, and body mass index did not have any effect (p > 0.05) after COVID-19 vaccination. Taking all results together, here, we present factors that affected immune responses of individuals during the first vaccination campaign in Oaxaca, Mexico; however, vaccine surveillance during the post-pandemic phase needs further investigation.


  • Open Access

    Green Synthesis of Silver Nanoparticles Using Pecan Nut (Carya illinoinensis) Shell Extracts and Evaluation of Their Antimicrobial Activity

    by Alberto Antonio Neira-Vielma, Héctor Iván Meléndez-Ortiz, Josué Israel García-López, Saúl Sanchez-Valdes, Mario Alberto Cruz-Hernández, Josefina Guadalupe Rodríguez-González, Sonia Noemí Ramírez-Barrón

    Nowadays, the increase in bacteria resistant to multiple antibiotics has become a real threat to the human health, forcing researchers to develop new strategies. Silver nanoparticles (AgNPs) may be a viable solution to this problem. The green synthesis of AgNPs is considered a green, ecological and low-priced process that provides small and biocompatible nanostructures with antimicrobial activity with a potential application in medicine. In this work, pecan nut shell extracts were analyzed in order to determine their viability for the production of AgNPs. These NPs were synthesized using an extract rich in bioactive molecules, varying the reaction time and silver nitrate (AgNO3) concentration. AgNPs production was confirmed by FT-IR, UV-Vis and EDX spectroscopy, while their morphology and size were determined by transmission electron microscopy (TEM) and dynamic light scattering (DLS). The antibacterial activity of AgNPs was evaluated by the agar diffusion method against Salmonella typhi, Staphylococcus aureus and Proteus mirabilis. The results showed that it is possible to obtain nanoparticles from an extract rich in antioxidant molecules with a size between 39.9 and 98.3 nm with a semi-spherical morphology. In addition, it was shown that the reaction time and the concentration of the precursor influence the final nanoparticles size. Antimicrobial tests showed that there is greater antimicrobial inhibition against Gram-negative than Gram-positive microorganisms, obtaining inhibition zone from 0.67 to 5.67 mm.